SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Corixa [CRXA] - cancer vaccines -- Ignore unavailable to you. Want to Upgrade?


To: Vector1 who wrote (102)10/30/2001 5:31:13 PM
From: Micawber  Read Replies (1) | Respond to of 222
 
3:50PM IDEC Pharm (IDPH) 58.74 +1.85 (+3.3%): Banc of America Sec positive on stock; says competitor to company's Zevalin drug will not be reviewed at Advisory Panel meeting on Dec 5/6; raises chances that Zevalin will be launched without any competition

Stock was selling off on big volume prior to this announcement hitting the wires. Please tell me it's just a rumor, CRXA.